{"id":174140,"date":"2026-09-25T14:07:12","date_gmt":"2026-09-25T14:07:12","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/174140\/"},"modified":"2026-09-25T14:07:12","modified_gmt":"2026-09-25T14:07:12","slug":"pharmalittle-fda-nominee-grilled-novo-licenses-drug-delivery-tech","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/174140\/","title":{"rendered":"PHarmalittle: FDA nominee grilled, Novo licenses drug delivery tech"},"content":{"rendered":"<p class=\"wp-block-paragraph\">And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to tidy up around the castle, catch up on our reading, and promenade with the official mascots. We also expect to hold another listening party, where the rotation will likely include <a href=\"https:\/\/youtu.be\/Trcq0rtZMi8?si=3bUa7rTPTaqDmmzn\" id=\"https:\/\/youtu.be\/Trcq0rtZMi8?si=3bUa7rTPTaqDmmzn\" target=\"_blank\" rel=\"noopener nofollow\">this<\/a>, <a href=\"https:\/\/youtu.be\/JdC21AhUqNg?si=Zb078eHuDMmiljYG\" id=\"https:\/\/youtu.be\/JdC21AhUqNg?si=Zb078eHuDMmiljYG\" target=\"_blank\" rel=\"noopener nofollow\">this<\/a>, <a href=\"https:\/\/youtu.be\/1T_DrRPYaNs?si=gp3t8X12i7ccrvkW\" id=\"https:\/\/youtu.be\/1T_DrRPYaNs?si=gp3t8X12i7ccrvkW\" target=\"_blank\" rel=\"noopener nofollow\">this<\/a>, <a href=\"https:\/\/youtu.be\/VahWm9gWZv0?si=sGhCruNPZItAVJgR\" id=\"https:\/\/youtu.be\/VahWm9gWZv0?si=sGhCruNPZItAVJgR\" target=\"_blank\" rel=\"noopener nofollow\">this<\/a>, <a href=\"https:\/\/youtu.be\/JpNRCG3Kceg?si=-x4tHMUV_LPV9KNm\" id=\"https:\/\/youtu.be\/JpNRCG3Kceg?si=-x4tHMUV_LPV9KNm\" target=\"_blank\" rel=\"noopener nofollow\">this<\/a> and <a href=\"https:\/\/youtu.be\/nEGIPGQcGaI?si=rxwud7VHTVbG7ikM\" id=\"https:\/\/youtu.be\/nEGIPGQcGaI?si=rxwud7VHTVbG7ikM\" target=\"_blank\" rel=\"noopener nofollow\">this<\/a>. And what about you? Some distraction from the world at large may be in order and there is nothing like a romp through an apple orchard or pumpkin patch to lift the spirits. If the weather does not cooperate, though, you could always binge-watch something on the telly or cook up an exotic meal. Or perhaps make time to see someone special. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon. \u2026<\/p>\n<p class=\"wp-block-paragraph\">Heidi Overton, President Trump\u2019s nominee to lead the U.S. Food and Drug Administration, was grilled by senators on hot button topics like China, vaccines, and abortion access in her hearing before the committee that will decide whether to send her nomination for a vote of the full Senate, but revealed very little of her own feelings on top issues facing the agency, <a href=\"https:\/\/www.statnews.com\/2026\/09\/24\/fda-commissioner-nominee-heidi-overton-senate-hearing-dodges-questions\/\" id=\"https:\/\/www.statnews.com\/2026\/09\/24\/fda-commissioner-nominee-heidi-overton-senate-hearing-dodges-questions\/\" rel=\"nofollow noopener\" target=\"_blank\">STAT<\/a> writes. Instead, she referred repeatedly to existing agency guidance and approvals for products like childhood vaccines and the abortion drug mifepristone \u2014 without saying whether she would endorse updating those guidances or altering approvals to satisfy the desires of Trump or health secretary Robert F. Kennedy Jr.<\/p>\n<p class=\"wp-block-paragraph\">Novo Nordisk agreed to pay up to $1.3 billion to license and develop N<a href=\"https:\/\/www.wsj.com\/market-data\/quotes\/SE\/XSTO\/NANEXA\" target=\"_blank\" rel=\"noreferrer noopener nofollow\">anexa\u2019s<\/a>\u00a0drug delivery technology in a deal that could cut the frequency that patients need to inject its obesity and diabetes\u00a0drugs, <a href=\"https:\/\/www.wsj.com\/health\/pharma\/novo-nordisk-to-pay-up-to-1-3-billion-for-nanexas-drug-delivery-technology-395b3770\" id=\"https:\/\/www.wsj.com\/health\/pharma\/novo-nordisk-to-pay-up-to-1-3-billion-for-nanexas-drug-delivery-technology-395b3770\" target=\"_blank\" rel=\"noopener nofollow\">The Wall Street Journal<\/a> writes. The deal covers Nanexa\u2019s PharmaShell technology, which is designed to enable controlled and sustained release of active pharmaceutical ingredients through an ultra-thin coating applied to individual drug particles. Under the exclusive deal, Novo licensed Nanexa\u2019s technology in up to five development programs covering different drug administration frequencies, with the companies targeting monthly and quarterly administration.<\/p>\n<p class=\"restricted-text\">STAT+ Exclusive Story<\/p>\n<p class=\"restricted-login\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t<img decoding=\"async\" class=\"restricted-content-breaker-bg\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/09\/1790345232_873_stat-plus-breaker-bg.png\" alt=\"STAT+\"\/><\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n\t\t\t\t\t\t<img decoding=\"async\" class=\"stat-plus-logo\" src=\"https:\/\/www.statnews.com\/wp-content\/themes\/stat\/images\/stat-plus-logo-white.svg\" alt=\"STAT+\"\/><br \/>\n\t\t\t\t\t<\/a><\/p>\n<p>\t\t\t\tThis article is exclusive to STAT+ subscribers<br \/>\n\t\t\t\tUnlock this article \u2014 plus in-depth analysis, newsletters, premium events, and news alerts.<\/p>\n<p class=\"restricted-content-breaker-wrapper-cta mobile\">Already have an account? <a href=\"https:\/\/www.statnews.com\/login\/\" data-stat-login=\"\" data-stat-paywall-cta=\"breaker login cta mobile\" rel=\"nofollow noopener\" target=\"_blank\">Log in<\/a><\/p>\n<p>\t\t\t\t\t\tIndividual plans<\/p>\n<p>\t\t\t\t\t\tGroup plans<\/p>\n<p>\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button view-all\" data-stat-paywall-cta=\"breaker view all plans\" aria-label=\"View All Plans\" rel=\"nofollow noopener\" target=\"_blank\">View All Plans<\/a><\/p>\n<p class=\"restricted-content-text\">\n\t\t\t\t\t\tTo read the rest of this story subscribe to STAT+.\t\t\t\t\t<\/p>\n<p>\t\t\t\t\t<a href=\"https:\/\/www.statnews.com\/stat-plus\/\" class=\"stat-button restricted-button\" data-stat-paywall-cta=\"breaker subscribe cta 1\" rel=\"nofollow noopener\" target=\"_blank\">Subscribe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"And so, another working week will soon draw to a close. Not a moment too soon, yes? This&hellip;\n","protected":false},"author":2,"featured_media":174141,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[272,6268,359],"class_list":["post-174140","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-novo-nordisk","tag-pharmalittle","tag-stat"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/117332073020502804","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/174140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=174140"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/174140\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/174141"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=174140"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=174140"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=174140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}